drugset / Trial / NCT00990847

Nebulized Procaterol Versus Nebule Salbutamol for the Treatment of Moderate Acute Asthma

NCT00990847

Phase 3 Completed 140 enrolled PT Otsuka Indonesia
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare the efficacy and safety of nebule procaterol with nebule salbutamol in the treatment of moderate acute asthma.

Timeline

Start
2007-06
Primary completion
2008-04
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Procaterol Other / unclassified 50 ug Other
Subject Salbutamol Unknown 2.5 mg Other

Indications